• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:廖雯,侯文婧,温爱萍.基于FAERS数据库的孟鲁司特钠致儿童不良事件信号挖掘与分析[J].药学研究,2025,44(3):307-312[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2356次   下载 790次 本文二维码信息
码上扫一扫!
基于FAERS数据库的孟鲁司特钠致儿童不良事件信号挖掘与分析
廖雯,侯文婧,温爱萍
字体:加大+|默认|缩小-
(首都医科大学附属北京友谊医院药剂科,北京 100050)
摘要:
目的 基于美国食品药品监督管理局不良事件报告系统(FAERS)数据库挖掘孟鲁司特钠上市后致儿童安全警戒信号,为临床安全用药提供参考。方法 运用比例失衡分析法,包括报告比值比法、比例报告比值法,对FAERS数据库收录的从2004年第一季度至2023年第一季度期间,涉及孟鲁司特钠引发的儿童不良事件信号进行筛查与分析。结果 总计搜集到与孟鲁司特钠相关的病例报告12 148份,其中发现226例阳性反应。这些阳性反应分布在18个不同的系统与器官类别中,按发生频次排序,孟鲁司特钠发生频次最多的不良信号分别是攻击、焦虑、异常行为、抑郁、自杀想法,均可见于其药品说明书。按信号强度排序,孟鲁司特钠诱发的视物变形以及导致的米费综合征均未被其药品说明书提及。结论 医务人员应高度关注孟鲁司特钠可能引发的神经系统与精神系统不良事件,特别是在对儿童及有相关病史的患者进行治疗时,并且留意说明书未提及的不良反应。
关键词:  孟鲁司特钠  儿童  FAERS数据库  信号挖掘
DOI:10.13506/j.cnki.jpr.2025.03.016
基金项目:
出版日期:2025-03-25
Data mining and analysis of adverse events signals for Montelukast Sodium in children based on FAERS database
LIAO Wen,HOU Wenjing,WEN Aiping
(Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University,Beijing 100050, China)
Abstract:
Objective To analyze post-marketing adverse event reported for Montelukast Sodium in children based on the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS), and provide references for the safe clinical using of the drug. Methods Disproportion analysis techniques, including the reporting odds ratio and proportional reporting ratio, were used to screen and analyze the signals of adverse events in children involving Montelukast Sodium from the FAERS database between the first quarter of 2004 and the first quarter of 2023. Results A total of 12 148 case reports related to Montelukast Sodium were collected, of which 226 were found to be positive. These positive reactions were distributed in 18 different system and organ categories.According to the frequency of occurrence, the most frequent adverse signals of Montelukast Sodium are aggression, anxiety, abnormal behavior, depression, and suicidal thoughts, which can be seen in the drug label. In order of signal intensity, Montelukast induced visual deformations and the resulting Milfie syndrome were not mentioned in the drug label. Conclusion Health care professionals should be extremely concerned about the possible neurological and psychiatric adverse events of Montelukast Sodium, especially when treating children and patients with related medical histories. And they should pay attention to adverse reactions not mentioned in the instructions.
Key words:  Montelukast Sodium  Children  FAERS database  Signal mining
今日访问量:2772    总访问量:55339354
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司